Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review

Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review

The four-component meningococcal serogroup B vaccine (4CMenB) is indicated for the prevention of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup B. Co-administering 4CMenB with other vaccines may improve vaccine uptake provided that the safety and immunogenicity of ei...

Full description

Bibliographic Details
Main Authors: Véronique Abitbol, Woo-Yun Sohn, Michael Horn, Marco Aurelio P. Safadi
Format: Article
Language:English
Published: Taylor & Francis Group 2023-08-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
4cmenb
meningitis b
invasive meningococcal disease
co-administration
concomitant administration
Online Access:http://dx.doi.org/10.1080/21645515.2023.2245705

Internet

http://dx.doi.org/10.1080/21645515.2023.2245705

Similar Items